Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11

Mantle cell lymphoma (MCL) shows a clinical aggressiveness that varies from patient to patient. Despite major advances in outcomes with current immunochemotherapy, the future development of therapies requires risk stratification to tailor therapy intensity. Within the group of reference pathologists...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Virchows Arch
Autores principales: Croci, Giorgio A., Hoster, Eva, Beà, Sílvia, Clot, Guillem, Enjuanes, Anna, Scott, David W., Cabeçadas, José, Veloza, Luis, Campo, Elias, Clasen-Linde, Erik, Goswami, Rashmi S., Helgeland, Lars, Pileri, Stefano, Rymkiewicz, Grzegorz, Reinke, Sarah, Dreyling, Martin, Klapper, Wolfram
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7415076/
https://ncbi.nlm.nih.gov/pubmed/31975037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00428-020-02750-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares